usdaily
I recently spoke at AACS' virtual Annual Meeting and I sat in on a presentation given by Jason Gilmore, a Senior VP at Allergan. His excellent talk was entitled: " A Year of Struggle: What 2020 taught me about aesthetics and what to do about it." Here are the highlights important for you to consider: He started with these interesting stats gathered in 2018: While 65 million people in the US would consider facial injectables, only 4 million have been treated. That's only 6% of the market so the room for growth is huge! And the International Market is even bigger. The demand for BOTOX has recovered and increased A LOT since COVID; however, Allergan spent a ton on marketing and increasing sales: But Allergan wasn't sure if this increase was the regular patient base coming back or new patients now wanting injectables. So, they were happy to learn these stats about consumer demand for injectables: 22% of BOTOX in Q3 of 2020 were patients NEW to the brand 37% of JUVED...